Business Context and Reporting Period
This Form 8-K is a current report filed by Data Knights Acquisition Corp. (not OneMedNet Corp, which is the target of a proposed business combination) on November 8, 2022. The filing addresses an adjustment to the terms of a proposed extension of the deadline for completing its initial business combination with OneMedNet Corporation.
Key Financial Metrics
The filing does not contain standard financial statements, revenue, profit, or cash flow data. It focuses on specific transactional terms regarding the company's Trust Account:
- Revised Extension Payment: The proposed payment to extend the business combination deadline has been increased to $0.045 per unit for each one-month extension.
- Original Proposal: The previously announced payment was $0.0333 per unit per month.
- Extension Terms: The amendment allows for up to nine one-month extensions at the company's option.
- Trust Account Usage: Proceeds in the Trust Account and interest earned will not be used to pay any potential excise tax liabilities.
Material Changes Versus Prior Period
The primary material change is the revision of the extension payment amount to mitigate risks associated with the Inflation Reduction Act of 2022 (IR Act). The IR Act imposes a 1% federal excise tax on certain stock repurchases (including redemptions) occurring after December 31, 2022. The increased deposit per unit is intended to provide a buffer or funding mechanism in light of this new tax liability, which could apply if the business combination closes after the end of 2022.
Guidance, Outlook, and Risks
- Excise Tax Risk: There is uncertainty regarding the application of the 1% excise tax on redemptions if the merger with OneMedNet closes after December 31, 2022. The tax liability would fall on the company, not the redeeming shareholders.
- Sponsor Indemnification: The Sponsor (Data Knights, LLC) intends to indemnify the company for any excise tax liabilities resulting from redemptions occurring after December 31, 2022, should the amendments be approved.
- Special Meeting: Stockholders will vote on the Extension Amendment and Trust Amendment at a Special Meeting on November 11, 2022.
- Regulatory Uncertainty: The final tax liability depends on Treasury regulations, the structure of the deal, and the volume of redemptions versus PIPE investments.
Investor Verification Checklist
- Verify the outcome of the Special Meeting of Stockholders scheduled for November 11, 2022, regarding the approval of the Extension Amendment.
- Confirm the definitive terms of the business combination with OneMedNet Corporation in the upcoming Proxy Statement.
- Monitor for final guidance from the U.S. Department of the Treasury regarding the calculation and application of the 1% excise tax on SPAC redemptions.
- Review the definitive Prospectus for details on the Sponsor's indemnification agreement and the mechanics of paying any potential excise tax.